Johnson & Johnson Rises on Q4 Beats, Coronavirus Vaccine Hopes

Johnson & Johnson (NYSE:JNJ) delivered an encouraging set of quarterly results on Tuesday, which included a promising -- albeit limited -- update on its coronavirus vaccine candidate.